Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety and Efficacy of the NOVA Intracranial Drug-eluting Stent System in "real World" Patients with Intracranial Atherosclerotic Stenosis: a Prospective, Multicenter, Post-marketing Registry Clinical Study (NOVA II)

NCT05692882 is registered in ClinicalTrials.gov with Sino Medical Sciences Technology Inc. as lead sponsor.

NCT NCT05692882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety and Efficacy of the NOVA Intracranial Drug-eluting Stent System in "real World" Patients with Intracranial Atherosclerotic Stenosis: a Prospective, Multicenter, Post-marketing Registry Clinical Study (NOVA II)
Lead sponsor
Sino Medical Sciences Technology Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 16, 2023
Completion date
December 30, 2029
Enrollment
1,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

drug-eluting stents, intracranial arteriosclerosis, intracranial artery stenosis, stenosis artery